July 13, 2020
Masato Iwasaki, President, Japan Pharma Business Unit, Takeda Takeda Pharmaceutical aims to pull in 73% of its Japan sales from its five focus therapeutic areas - GI, rare diseases, plasma-derived therapies, oncology, and neuroscience - in FY2025, up from 48%...read more